Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Substance P ELISA Kit (AC3826)
Cat.#: ASET-2415
Specifications
Description Mouse Substance P ELISA Kit allows for the in vitro quantitative determination of mouse Substance P concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 4.688 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 7.813-500 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1135 Human KCNK17 ELISA Kit (AC2546) Quantitative inquiry ASET-1478 Mouse Mitofusin 2 ELISA Kit (AC2889) Quantitative inquiry ASET-1434 Rat Rabphilin 3A ELISA Kit (AC2845) Quantitative inquiry ASET-1765 Mouse POMC ELISA Kit (AC3176) Quantitative inquiry ASET-1632 Rat CaSR ELISA Kit (AC3043) Quantitative inquiry ASET-1350 Human Clathrin Light Chain ELISA Kit (AC2761) Quantitative inquiry ASET-2534 Human Orexin Receptor 2 ELISA Kit (AC3945) Quantitative inquiry ASET-1889 Human Toca-1 ELISA Kit (AC3300) Quantitative inquiry ASET-1725 Human NPEPPS ELISA Kit (AC3136) Quantitative inquiry ASET-1642 Human Laminin ELISA Kit (AC3053) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket